Application no. and date | 11784992.7 (espacenet) (Federated) (European Patent Register), 20111115 | Patent/reg. no. and date | DK/EP 2640718, 20180328 | Publication date | 20130925 | Priority no. and date | DE 102010044131, 20101118 | EP pub. no. and date |
EP 2640718 20130925 | Effective date | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50 40789 Monheim am Rhein, DE | Applicant ref. no. | BBS BHC101047PCT-EP | Inventor | Militzer, Hans-Christian, Waldweg 2
51519 Odenthal, DE, GRIES, Jörg, August-Macke-Weg 34
42781 Haan, DE, KOEP, Stefan, Saarlandring 31
58256 Ennepetal, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61P 9/00 (2006.01) , C07D 403/14 (2006.01) | Title | SUBSTITUERET NATRIUM-1H-PYRAZOL-5-OLAT | Int. application no. | EP2011070099 | Int. publication no. | WO2012065967 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|